Intraocular inflammation and visual acuity may improve for up to 6 months in patients taking a single dose of dexamethasone for noninfectious intermediate or posterior uveitis, a study found.
Author: OphthalmologyWeb
Acuminder(TM) Tool Helping To Change Contact Lens Wearing Behavior, Survey Shows
Even though eye care doctors and manufacturers provide instructions about caring for and wearing contact lenses, studies show that many contact lens wearers do not comply with the recommended replacement frequencies and fail to discard their lenses aft…
Highlights from Hawaiian Eye 2011
Featured Article
Intravitreal Implant May Reduce Inflammation, Improve Vision In Patients With Uveitis
Intraocular inflammation and visual acuity may improve for up to 6 months in patients taking a single dose of dexamethasone for noninfectious intermediate or posterior uveitis, a study found.
Ocular Therapeutix, Inc. Completes Series D Financing To Support Phase II Sustained Drug Delivery Clinical Trials
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures,…
Ocular Therapeutix, Inc. Completes Series D Financing To Support Phase II Sustained Drug Delivery Clinical Trials
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures,…
Ocular Therapeutix, Inc. Completes Series D Financing To Support Phase II Sustained Drug Delivery Clinical Trials
Ocular Therapeutix, Inc. announced today that it has closed a $14 million Series D round of financing. The round was led by Ascension Health Ventures of St. Louis, Missouri, with continued participation by existing investors including Polaris Ventures,…
Novel Drug Delivery Devices Show Promise For Treating Retinal Disorders
Several new devices designed to deliver drugs to the posterior pole may address the drawbacks of current technologies, according to a speaker here. However, the technology has yet to catch up with the therapeutic need.
Webinar: Results of 135 Eyes Treated with Diabetic Macula Edema
Featured Article
1 Donor Cornea, 2 Patients Helped
SAN FRANCISCO-German researcher Claus Cursiefen, MD, also affiliated with Harvard School of Medicine, reports good results with a new surgical strategy that uses a single donor cornea to help two patients with differing corneal diseases. In the United …
When Premium Lenses Go Wrong
Featured Article
Novel Drug Delivery Devices Show Promise For Treating Retinal Disorders
Several new devices designed to deliver drugs to the posterior pole may address the drawbacks of current technologies, according to a speaker here. However, the technology has yet to catch up with the therapeutic need.
Threats In Health Care Reform Law Drive Agenda For New "Change"
WASHINGTON, D.C. – With renewed Congressional fervor surrounding the health care law, the American Academy of Ophthalmology has made repealing the law’s egregious components and protecting Medicare payments as top priorities. The Academy determined its…
Threats In Health Care Reform Law Drive Agenda For New "Change"
WASHINGTON, D.C. – With renewed Congressional fervor surrounding the health care law, the American Academy of Ophthalmology has made repealing the law’s egregious components and protecting Medicare payments as top priorities. The Academy determined its…
Threats In Health Care Reform Law Drive Agenda For New "Change"
WASHINGTON, D.C. – With renewed Congressional fervor surrounding the health care law, the American Academy of Ophthalmology has made repealing the law’s egregious components and protecting Medicare payments as top priorities. The Academy determined its…
Threats In Health Care Reform Law Drive Agenda For New "Change"
WASHINGTON, D.C. – With renewed Congressional fervor surrounding the health care law, the American Academy of Ophthalmology has made repealing the law’s egregious components and protecting Medicare payments as top priorities. The Academy determined its…
2010 Ophthalmology in Review: Anterior Segment
Technology Spotlight
Judicious Use Of Anti-VEGF Agents Advised As ‘reasonable’
The judicious use of anti-VEGF agents for the treatment of age-related macular degeneration is reasonable, considering the biological and clinical responses, a speaker said here.
Judicious Use Of Anti-VEGF Agents Advised As ‘reasonable’
The judicious use of anti-VEGF agents for the treatment of age-related macular degeneration is reasonable, considering the biological and clinical responses, a speaker said here.
Threats In Health Care Reform Law Drive Agenda For New "Change"
WASHINGTON, D.C. – With renewed Congressional fervor surrounding the health care law, the American Academy of Ophthalmology has made repealing the law’s egregious components and protecting Medicare payments as top priorities. The Academy determined its…